Company Active LTD

Company profile

Genetic Microdevices Limited

Genetic Microdevices Analysing Proteins and DNA Analysing proteins and DNA

Genetic Microdevices Limited is a UK company with status active founded in 2005 based in London.

CRN
05489668
Founded
2005
Age
21

Overview

Legal name
GENETIC MICRODEVICES LIMITED
Region
London
Registered address
TENNYSON
198 SHEEN ROAD
RICHMOND
SURREY
ENGLAND
TW10 5AL
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

14 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

23 Jun
2005

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2012
Funded years
2012, 2014, 2020, 2022
Age at first award
6 years

Projects

2022 Collaborative R&D Lead participant

Novel Immunoassay for CVD and Neurological Biomarkers, Delivered with Additive Layer Manufacturing Processes

1 Jul 2022 to 30 Jun 2025

Awarded
£979,974
Total cost £1,399,963

Genetic Microdevices Ltd has developed a small device - the QbQ chip- that can analyse proteins in blood with unprecedented sensitivity, speed and cost. The chip can detect minute amounts of disease biomarkers in less than 15 minutes for a cost that resembles that of Lateral Flow Assays. Once the QbQ test chip becomes available it will revolutionise Point...

2020 Collaborative R&D Lead participant

Validation of QbQ Technology for SARS_COV_2 Antigen & Anibody Testing

1 Oct 2020 to 30 Jun 2021

Awarded
£174,998
Total cost £218,748

The onset of the SARS-COV- 2 pandemic and subsequent lockdown created significant economic and social disruption worsening inequality, unemployment, community tensions and straining the NHS. The easing of the lockdown, currently underway, has reinforced the need to prevent an increase in new infections, to avoid another lockdown with its adverse economic,...

2014 GRD Proof of Concept Lead participant

Genetic Microdevices Ltd

1 Dec 2014 to 31 May 2016

Awarded
£99,973
Total cost £166,621

Genetic Microdevices Ltd has developed a revolutionary next generation device that analyses biological samples such as DNA, RNA and proteins with ultra-high performance. The device is based on a disposable plastic chip (CycloChipTM) that performs the analysis. Against competitors, the technology has demonstrated 10x higher resolution, 270x higher throughp...

2012 GRD Development of Prototype Lead participant

Disposable Microfluidic Device for Ultra High Performance Genomic and Proteomic Analyses

1 Jun 2012 to 31 May 2014

Awarded
£249,577
Total cost £595,507

Genetic Microdevices Ltd has developed a disruptive technology that analyses proteins and DNA with ultra-high performance. The device is based on a disposable analysis chip (CycloChipTM) . Protein and DNA analysis are central to many bio-analytical procedures used widely in drug development, research and diagnostics. Our device encompasses unique intellec...

Product types

Collaborative R&D GRD Development of Prototype GRD Proof of Concept